Form 4: Guardant Health CTO Darya Chudova Reports Routine Stock Transactions and ESPP Acquisition

Guardant Health's Chief Technology Officer, Darya Chudova, reported the acquisition of common stock through RSU vesting and subsequent sale of shares to cover tax obligations, alongside an Employee Stock Purchase Plan acquisition.

Summary

• Darya Chudova, Chief Technology Officer of Guardant Health, Inc. (GH), reported transactions on June 1, 2025.
• She acquired 316 shares of common stock through the vesting of Restricted Stock Units (RSUs) at a price of $0.
• Concurrently, 161 shares of common stock were disposed of at a price of $40.62 to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Chudova beneficially owns 79,812 shares of common stock directly.
• Additionally, 859 shares were acquired under Guardant Health's Employee Stock Purchase Plan (ESPP) on May 14, 2025.
• The RSU award was granted on November 2, 2021, with 3,157 shares outstanding as of May 3, 2023, and vests in equal quarterly installments on the anniversary of September 1, 2022, fully vesting by September 1, 2025.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to the routine vesting of equity awards and participation in the ESPP, indicating ongoing employee compensation and engagement. The share disposal is for tax purposes, which is a neutral, expected event.

Positives

• Acquisition of 316 shares of common stock through the vesting of Restricted Stock Units (RSUs) indicates a scheduled compensation event.
• An additional 859 shares were acquired under the Employee Stock Purchase Plan (ESPP), demonstrating continued participation in employee ownership programs.

Negatives

• 161 shares of common stock were disposed of to cover tax withholding obligations, which is a common practice but reduces the direct shareholding.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The transactions represent routine insider compensation and tax management, which is generally expected and has minimal direct impact on the broader shareholder base. It indicates continued alignment of management interests with company performance through equity ownership.

Next Steps

• Remaining Restricted Stock Units (RSUs) are scheduled to fully vest by September 1, 2025.

Key Dates

Keywords

Guardant Health, GH, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Employee Stock Purchase Plan, ESPP, Darya Chudova, Chief Technology Officer, Stock Transactions, Beneficial Ownership